Scientists from TIFR, Mumbai and Columbia University, USA team up to understand the binding mechanism of kinase inhibitors—a step toward designing better inhibitors.
This is a companion discussion topic for the original entry at https://indiabioscience.org/news//how-a-kinase-inhibitor-withstands-gatekeeper-residue-mutations.